| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.26 | 0.02 |